Business Wire

Veza, the Data Security Platform Built on the Power of Authorization, Announces Partnership with Google Cloud

19.7.2022 16:00:00 EEST | Business Wire | Press release

Share

Veza, the data security platform built on the power of authorization, announces today that the company has entered a partnership with Google Cloud, including product integration that enables Google Cloud customers to harness the capabilities of Veza’s data security platform across their multi-cloud ecosystem.

Veza, which recently launched in April 2022 after two years of building in stealth, makes it easy to understand, manage, and control who can and should take what action on what data. With this new integration, Google Cloud customers can now directly access the capabilities of Veza’s authorization-based data security platform integrated with Google Cloud Policy Analyzer to identify, manage, and control external identities and service accounts to Google Cloud services (Looker, BigQuery, and more). This partnership furthers the relationship between Google and Veza, which began in 2021 when GV led the Series B investment in Veza and GV Partner Karim Faris joined Veza Board of Directors.

“The cloud is quickly becoming the primary footprint for organizations. By prioritizing and investing in security, Google Cloud has earned a differentiated position in the market,” said Tarun Thakur, Co-founder and CEO, Veza. “The initial product integration between Veza and Google Cloud, publicly demonstrated at the Google Cloud Security Summit in May this year, is a powerful example of how intelligence from Veza’s Authorization Graph can bolster the data security of Google Cloud customers. It shows how identity-to-data relationship insights from the Veza platform can be pulled directly into the Google Cloud Policy Analyzer, allowing customers to secure both Google Cloud data (Looker, BigQuery, Google Storage Buckets, etc.) to which multi-cloud identities (AD, Azure AD, Okta, etc.) have permissions and multi-cloud data (AWS, Snowflake, etc.) that is being accessed by Google Cloud identities.”

“Securing cloud environments and data from cybercrime and threats is a key priority of organizations across the globe,” said Sunil Potti, General Manager and Vice President, Cloud Security, Google Cloud. “With Veza’s platform now available alongside Google Cloud’s secure and global infrastructure, customers will be able to quickly deploy the solutions they need to better understand, control, and securely take action on their data across their multi-cloud environments.”

Veza’s data security platform aggregates identity information from humans, service accounts, and cloud IAM entities, and authorization data from apps and data systems, giving organizations a centralized, SaaS-based control plane to visualize, manage, and control data access controls through Veza’s Authorization Graph. Veza integrates with cloud identity providers, SaaS and custom apps, and data systems, and translates system-specific entitlements and permissions into a common, human-understandable business language, visualized in the platform as effective permissions. The platform brings a novel approach to data security by enabling organizations to address key data security use cases across access reviews and certifications for SaaS apps and data systems, privileged access management to data and apps, data lake security and governance, management of cloud entitlements, and much more. It delivers prioritized insights, provides access workflows, and actionable recommendations for remediation of over-privileged accounts, enabling security and IT teams to correct anomalies and right-size their organization’s permissions to protect against ransomware and other data breaches.

As organizations continue to adapt to the evolving demands of hybrid remote and in-office work, multi-cloud and hybrid-cloud environments — those with multiple providers of disparate data, app, compute, and infrastructure systems — are becoming the norm. According to the Flexera 2022 State of the Cloud Report, 89% of companies surveyed are multi-cloud, with only 2% operating in single private clouds and 9% in single public clouds. This trend is leading to a distributed web of data, relationships, and access points that are changing and difficult to track and secure.

Veza and Google Cloud already have a number of joint customers deployed across the industries of SaaS software, marketing technology, and media, including Vox Media.

“To support Vox Media’s growth and increasing M&A activity without compromising security, we need to ensure that across all of our brands, the right users have access only to the data they need access to, and that we have full visibility over what they can do with that data,” says Ateeb Ahmad , Senior Director, IT Infrastructure, Vox Media. With Veza and Google Cloud working together, we’ve been able to seamlessly manage access controls over our data for our largest merger to date, and tightly scope identity-to-data permissions even as our footprint with Google Cloud and other technologies grows.”

“The greatest gifts of the multi-cloud and the generational architectural shift of the modern data systems are also its greatest risks: securing data, scalability, flexibility, and seamless collaboration,” says Thakur. “When organizations enable workers to reach from one cloud to another to leverage data across their entire multi-cloud ecosystem, they foster growth, enable more intelligence, and promote agility. However, such apps and data systems are also more porous and are at increased risk of cybercrime and ransomware. We purpose-built Veza’s Core Authorization Platform for the multi-cloud so that organizations can implement strong access governance policies - Veza continuously evaluates these policies and enables both automated workflows for access reviews, automated access removal for toxic and stale combinations, and facilitates access grant and request for any app, data, and service.”

Learn More:

Google Cloud Security Summit - Best practices for defining and enforcing policies across your Google Cloud environment

Veza for Google Cloud demo
Veza for Google Cloud
Veza Free Trial - sign up here

About Veza

Veza is the data security platform built on the power of authorization. Our platform is purpose-built for hybrid multi-cloud environments to help you use and share your data safely. Veza makes it easy to understand, manage, and control who can and should take what action on what data. We organize authorization metadata across identity providers, data systems, cloud service providers, and SaaS applications — all to address the toughest data security challenges of the modern era. Founded in 2020, the company is funded by top-tier investors including Accel, Bain Capital, Ballistic Ventures, Blackstone, GV, Norwest Venture Partners, and True Ventures. To learn more, please visit us at veza.com. You can follow us on LinkedIn or on Twitter @vezainc.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Aircover PR
veza@aircoverpr.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye